Pharmaniaga Bhd
KLSE:PHARMA
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.3
0.47
|
Price Target |
|
We'll email you a reminder when the closing price reaches MYR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one PHARMA stock under the Base Case scenario is 0.82 MYR. Compared to the current market price of 0.36 MYR, Pharmaniaga Bhd is Undervalued by 56%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Pharmaniaga Bhd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for PHARMA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Pharmaniaga Bhd
Balance Sheet Decomposition
Pharmaniaga Bhd
Current Assets | 1.3B |
Cash & Short-Term Investments | 66.8m |
Receivables | 610.2m |
Other Current Assets | 596m |
Non-Current Assets | 806.6m |
PP&E | 603.2m |
Intangibles | 151.1m |
Other Non-Current Assets | 52.3m |
Current Liabilities | 2.2B |
Accounts Payable | 1B |
Short-Term Debt | 756.5m |
Other Current Liabilities | 397.2m |
Non-Current Liabilities | 197.6m |
Long-Term Debt | 127.7m |
Other Non-Current Liabilities | 69.9m |
Earnings Waterfall
Pharmaniaga Bhd
Revenue
|
3.5B
MYR
|
Cost of Revenue
|
-3.2B
MYR
|
Gross Profit
|
323.6m
MYR
|
Operating Expenses
|
-308.5m
MYR
|
Operating Income
|
15.1m
MYR
|
Other Expenses
|
-71.4m
MYR
|
Net Income
|
-56.3m
MYR
|
Free Cash Flow Analysis
Pharmaniaga Bhd
MYR | |
Free Cash Flow | MYR |
PHARMA Profitability Score
Profitability Due Diligence
Pharmaniaga Bhd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
Score
Pharmaniaga Bhd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
PHARMA Solvency Score
Solvency Due Diligence
Pharmaniaga Bhd's solvency score is 31/100. The higher the solvency score, the more solvent the company is.
Score
Pharmaniaga Bhd's solvency score is 31/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PHARMA Price Targets Summary
Pharmaniaga Bhd
According to Wall Street analysts, the average 1-year price target for PHARMA is 0.35 MYR with a low forecast of 0.34 MYR and a high forecast of 0.36 MYR.
Dividends
Current shareholder yield for PHARMA is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Pharmaniaga Bhd.operates as an investment holding company. The company is headquartered in Shah Alam, Selangor. The firm is principally engaged in the research and development, manufacturing of generic drugs and medical devices, logistics and distribution, sales, and marketing, as well as community pharmacy. The Company’s segment includes Logistics and distribution, Manufacturing, and Indonesia. The Logistics and distribution segment is engaged in the distribution, trading, and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia. The Manufacturing segment is involved in manufacturing of pharmaceutical products in Malaysia. The Indonesia segment is engaged manufacturing and distribution of pharmaceutical and medical products in Indonesia. Its subsidiaries include Idaman Pharma Manufacturing Sdn. Bhd., Pharmaniaga Manufacturing Berhad, Pharmaniaga LifeScience Sdn. Bhd., Pharmaniaga Logistics Sdn. Bhd., and Pharmaniaga Marketing Sdn. Bhd.
Contact
IPO
Employees
Officers
The intrinsic value of one PHARMA stock under the Base Case scenario is 0.82 MYR.
Compared to the current market price of 0.36 MYR, Pharmaniaga Bhd is Undervalued by 56%.